William E. Winter
Walter Reed Army Medical Center
26 Papers
208 Citations
William E. Winter is an academic researcher from Walter Reed Army Medical Center. The author has contributed to research in topics: Medicine & Laparoscopy. The author has an hindex of 14, co-authored 26 publications.
Chat about Author
Papers
Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter,G. Larry Maxwell,Chunqiao Tian,Jay W. Carlson,Robert F. Ozols,Peter G. Rose,Maurie Markman,Deborah K. Armstrong,Franco M. Muggia,William McGuire +9 more
TL;DR: Age, PS, tumor histology, and residual tumor volume were independent predictors of prognosis in patients with stage III EOC and can be used to identify patients with poor prognosis and to design future tailored randomized clinical trials.
872
Tumor Residual After Surgical Cytoreduction in Prediction of Clinical Outcome in Stage IV Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study
William E. Winter,G. Larry Maxwell,Chunqiao Tian,Michael J. Sundborg,G. Scott Rose,Peter G. Rose,Stephen C. Rubin,Franco M. Muggia,William McGuire +8 more
TL;DR: Findings suggest that ultraradical cytoreductive procedures might be targeted for selected patients in whom microscopic residual disease is achievable, and patients with less than 5.0 cm of disease initially and significant disease and/or comorbidities precluding microscopic cytoreduction may be considered for alternative therapeutic options other than primary cytore abduction.
413
Surgical staging in patients with ovarian tumors of low malignant potential
William E. Winter,Paul R. Kucera,William H. Rodgers,John W. McBroom,Cara H. Olsen,G. Larry Maxwell +5 more
TL;DR: Survival and recurrence rates were not significantly different between staged and unstaged patients who had surgery for low malignant potential tumors of the ovary.
129
Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.
William E. Winter,Jeffrey D. Seidman,Thomas C. Krivak,Suman Chauhan,Jay W Carlson,G. Scott Rose,Michael J. Birrer +6 more
TL;DR: A significant proportion of carcinosarcomas of the uterine corpus display immunoreactivity for c-kit, which may have an improved progression-free survival compared to KIT-negative tumors; however, further data are needed to determine whether this finding is confounded by stage.
62
Cervical adenocarcinoma in situ: a systematic review of therapeutic options and predictors of persistent or recurrent disease.
TL;DR: The reader will be able to summarize the current data on the treatment of adenocarcinoma in situ of the cervix, to outline potential treatment options for the patient with adeno-cervix cancer, and to list the factors associated with disease recurrence.
49